The Role of Non-Selective β-Blockers in Compensated Cirrhotic Patients without Major Complications

<i>Background and Objectives</i>: Non-selective &#946;-blockers (NSBB) could prevent decompensation and hepatocellular carcinoma (HCC) in cirrhotic patients with clinically significant portal hypertension (CSPH), but remained uncertain for compensated cirrhotic patients without major...

Full description

Bibliographic Details
Main Authors: Wen-Shuo Yeh, Shih-Cheng Yang, Chih-Ming Liang, Yu-Chi Li, Wei-Chen Tai, Chen-Hsiang Lee, Yao-Hsu Yang, Chien-Ning Hsu, Tzu-Hsien Tsai, Seng-Kee Chuah, Cheng-Kun Wu
Format: Article
Language:English
Published: MDPI AG 2019-12-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1010-660X/56/1/14